Bentley J. Fulcher
A5081535708- Mechanical Circulatory Support Devices
- Cardiac Arrest and Resuscitation
- Heart Failure Treatment and Management
- Intensive Care Unit Cognitive Disorders
- Cardiac Structural Anomalies and Repair
- Family and Patient Care in Intensive Care Units
- Long-Term Effects of COVID-19
- Tracheal and airway disorders
- Cardiac and Coronary Surgery Techniques
- Acute Kidney Injury Research
- Respiratory Support and Mechanisms
- Blood transfusion and management
- Frailty in Older Adults
- Delphi Technique in Research
Monash University
2020-2025
Australian and New Zealand Intensive Care Society
2020-2024
Austin Hospital
2022
The University of Melbourne
2022
Abstract Background There are few reports of new functional impairment following critical illness from COVID-19. We aimed to describe the incidence death or disability, and changes in health-related quality life patients after COVID-19 at 6 months. Methods In a nationally representative, multicenter, prospective cohort study illness, we determined prevalence disability months, primary outcome. measured mortality, return work with World Health Organization Disability Assessment Schedule 2.0...
The outcomes of survivors critical illness due to coronavirus disease (COVID-19) compared with non-COVID-19 are yet be established.
Patients receiving venoarterial extracorporeal membrane oxygenation (VA-ECMO) frequently develop arterial hyperoxaemia, which may be harmful. However, lower oxygen saturation targets also lead to harmful episodes of hypoxaemia. In this registry-embedded, multicentre trial, we randomly assigned adult patients VA-ECMO in an intensive care unit (ICU) either a conservative (target SaO2 92–96%) or liberal strategy 97–100%) through controlled administration via the ventilator and ECMO gas blender....
BACKGROUND: Long-term outcomes and quality of life have been identified as core patient-centered for venoarterial extracorporeal membrane oxygenation (VA-ECMO) research. The aim this study is to investigate the incidence death or new disability at 12 months after initiation VA-ECMO. METHODS: Prospective, multicenter, registry-embedded cohort in 26 hospitals Australia New Zealand from February 2019 through April 2023. Adult patients admitted a participating ICU who underwent VA-ECMO were...
<title>Abstract</title> <bold>Background: </bold>The optimal transfusion threshold for patients undergoing venoarterial extracorporeal membrane oxygenation (VA-ECMO) remains uncertain. <bold>Methods: </bold>We used data from OBLEX (ClinicalTrials.gov: NCT03714048), an international, prospective, observational study conducted across 12 centres in Australia, Europe, and North America between 2019 2022. The collected information on patient demographics, bleeding risk factors, practices during...
A core set of outcomes have been identified and published, which are essential to include in all clinical research evaluating the use extracorporeal membrane oxygenation critically ill patients, particularly regarding safety adverse events. The purpose this international modified Delphi study was determine measurement tools timing should be selected for outcome patients receiving oxygenation.This a two-round international, multidisciplinary web-based, study.Participants were from...
Although the criteria for initiation of venovenous extracorporeal membrane oxygenation (VV ECMO) are well defined, and timing VV ECMO decannulation less certain. The aim this study was to describe ventilation physiologic factors at time determine if these have association with mechanical or ICU length stay after decannulation.Multicenter, prospective cohort study.Eleven ICUs in Australia.Adult patients treated from March 19, 2019, September 20, 2020.Liberation ECMO.Of 87 receiving ECMO,...